Colonization screening positivity rates for novel multidrug-resistant organism healthcare containment responses during 2019-2022
Background: The CDC recommends a public health response when novel and targeted multidrug-resistant organisms (nMDROs), such as carbapenem-resistant organisms or Candida auris, are identified in healthcare settings in nonendemic areas. nMDRO responses are supported by healthcare-associated infection...
Saved in:
Main Authors: | Danielle Rankin (Author), Lucas Ochoa (Author), Guillermo Sanchez (Author), Kaitlin Forsberg (Author), Meghan Lyman (Author), Nijika Shrivastwa (Author), Maroya Walters (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outbreak response activities conducted by public health programs in healthcare facilities nationwide, August 2019-July 2020
by: Nijika Shrivastwa, et al.
Published: (2022) -
Predicting the regional impact of interventions to prevent and contain multidrug-resistant organisms
by: Samuel Cincotta, et al.
Published: (2022) -
Characterizing Response Capacity of Healthcare-Associated Infection/Antimicrobial Resistance Programs - US, 2019-2022
by: Nijika Shrivastwa, et al.
Published: (2024) -
An interactive patient transfer network and model visualization tool for multidrug-resistant organism prevention strategies
by: Rany Octaria, et al.
Published: (2023) -
Investigation of the first cluster of Candida auris cases among pediatric patients in the United States-Nevada, May 2022
by: Sophie Jones, et al.
Published: (2023)